DM
XERS icon

Deerfield Management’s Xeris Biopharma Holdings XERS Stock Holding History

Deerfield Management’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-52,230
Closed -$410K – 157
2025
Q4 		$410K Sell
52,230
-68,670
-57% -$540K 0.01% 133
2025
Q3 		$984K Buy
120,900
+98,326
+436% +$653K 0.02% 122
2025
Q2 		$105K Buy
+22,574
New +$103K ﹤0.01% 114
2024
Q2 		– Sell
-73,570
Closed -$163K – 578
2024
Q1 		$163K Buy
+73,570
New +$190K ﹤0.01% 345
2021
Q3 		– Sell
-6,553,398
Closed -$26.7M – 153
2021
Q2 		$26.7M Hold
6,553,398
– – 0.47% 70
2021
Q1 		$29.6M Buy
+6,553,398
New +$35.3M 0.62% 54
2020
Q3 		– Sell
-3,178,551
Closed -$8.46M – 115
2020
Q2 		$8.46M Sell
3,178,551
-254,740
-7% -$887K 0.25% 79
2020
Q1 		$6.7M Buy
3,433,291
+850,000
+33% +$3.66M 0.21% 79
2019
Q4 		$18.2M Buy
2,583,291
+274,625
+12% +$2.27M 0.58% 54
2019
Q3 		$22.7M Sell
2,308,666
-71,235
-3% -$800K 0.93% 37
2019
Q2 		$27.2M Buy
2,379,901
+24,765
+1% +$260K 0.98% 34
2019
Q1 		$23.6M Sell
2,355,136
-143,530
-6% -$1.84M 0.91% 38
2018
Q4 		$42.5M Hold
2,498,666
– – 1.7% 18
2018
Q3 		$43.9M Hold
2,498,666
– – 1.57% 24
2018
Q2 		$47.4M Buy
+2,498,666
New +$48.6M 1.67% 14

Other funds holding XERS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Deerfield Management's XERS Position: Q1 2026 in Review

Deerfield Management sold out of Xeris Biopharma Holdings (XERS) in Q1 2026, closing a stake of 52,230 shares — an estimated $410K sold.

Deerfield Management first reported a position in XERS in Q2 2018 and held it in 15 quarters. The position peaked at $47.4M in Q2 2018. 237 funds tracked by Wall St. Rank hold XERS as of Q1 2026.

  • Deerfield Management reported no remaining Xeris Biopharma Holdings position as of Q1 2026 after selling out during the quarter.
  • Deerfield Management sold 52,230 Xeris Biopharma Holdings shares in Q1 2026, an estimated $410K.
  • Deerfield Management first reported a position in Xeris Biopharma Holdings in Q2 2018 and held it in 15 quarters.
  • Deerfield Management's Xeris Biopharma Holdings position peaked at $47.4M in Q2 2018.
  • 237 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q1 2026.

Based on Deerfield Management's 13F filing for Q1 2026, filed 15 May 2026.